Back to News

Oppenheimer raises Pharvaris stock price target on trial results

Source: Investing.com

No financial news content was provided; the article text contains only a 403 access error.

AllMind Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Request Trial

Market Sentiment

Overall Sentiment

neutral

Sentiment Score

0.00

More News